Skip to content

Main Navigation

About us
Innovation and research
Pipeline
Partnering
- - - Our approach
    - Our partnerships
Investors
Media
Careers
COVID trial

test

Search

Recent Posts

Nykode Therapeutics – 4Q 2022 Financial Results – presentation
Nykode Therapeutics – 4Q 2022 Financial Results
Nycode Therapeutics – 4Q 2022 Financial Results – webcast
Nykode Therapeutics to announce financial results for the fourth quarter 2022 and host webcast presentation on February 28, 2023
Nykode Therapeutics Announces Collaboration with The GOG Foundation, Inc. to Conduct the VB-C-04 Trial in Advanced Cervical Cancer

Recent Comments

Vaccibody Granted Platform Patent in the US (16.02.15) | Sarsiaseed on Vaccibody Granted Platform Patent in the US
Vaccibody får viktig patent godkjent i USA (16.02.15) | Sarsiaseed on Vaccibody Granted Platform Patent in the US

Contact

Nykode Therapeutics ASA
Oslo Science Park
Gaustadalléen 21
0349 Oslo
Norway
Phone +47 22 95 81 93

Privacy statement
Cookie policy
Disclaimer